Testing the covenant

The approach to liability valuation and funding is critical for defined benefit pension funds. Life & Pensions brings together leading trustees to share their experiences. Nicholas Dunbar reports

pg19-chris-holden-jpg

Nick Dunbar, editor of Life & Pensions magazine.

Chris Holden, chairman of the £3 billion telent pension scheme, also known as the GEC Marconi scheme.

Helen James, director of Law Debenture Pension Trust Corporation, a firm of independent pension trustees.

Eric Hunt, head of pensions for BAA and secretary to the trustees of the £2.2 billion scheme.

Tony Watson, chairman of the £5 billion Marks and Spencer pension fund.

Nick Dunbar

The sponsor covenant is perhaps the most critical factor in UK defined

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

The new rules of market risk management

Amid 2020’s Covid-19-related market turmoil – with volatility and value-at-risk (VAR) measures soaring – some of the world’s largest investment banks took advantage of the extraordinary conditions to notch up record trading revenues. In a recent Risk.net…

ETF strategies to manage market volatility

Money managers and institutional investors are re-evaluating investment strategies in the face of rapidly shifting market conditions. Consequently, selective genres of exchange-traded funds (ETFs) are seeing robust growth in assets. Hong Kong Exchanges…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here